1. Home
  2. STKL vs BCYC Comparison

STKL vs BCYC Comparison

Compare STKL & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunOpta Inc.

STKL

SunOpta Inc.

HOLD

Current Price

$6.50

Market Cap

769.4M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.14

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKL
BCYC
Founded
1973
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
769.4M
360.7M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
STKL
BCYC
Price
$6.50
$5.14
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$7.50
$13.90
AVG Volume (30 Days)
1.2M
584.2K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
186.67
N/A
EPS
0.13
N/A
Revenue
$817,715,000.00
N/A
Revenue This Year
$6.84
N/A
Revenue Next Year
$33.58
N/A
P/E Ratio
$49.92
N/A
Revenue Growth
12.99
N/A
52 Week Low
$3.32
$4.24
52 Week High
$6.94
$9.55

Technical Indicators

Market Signals
Indicator
STKL
BCYC
Relative Strength Index (RSI) 68.77 54.14
Support Level $6.43 $5.03
Resistance Level $6.52 $5.90
Average True Range (ATR) 0.02 0.24
MACD -0.02 0.09
Stochastic Oscillator 58.33 81.08

Price Performance

Historical Comparison
STKL
BCYC

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own proprietary brands, including SOWN, Dream, and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut, and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada, and Others, out of which it derives maximum revenue from U.S.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: